Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase Through Multiple Mechanisms

av Lisabeth, Erika M., Fernandez, Carlos, Pasquale, Elena B.
Publicerad 2012

Eph Receptor Signaling and Ephrins

av Lisabeth, Erika M., Falivelli, Giulia, Pasquale, Elena B.
Publicerad 2013

The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras(G12D); Pdx1-Cre (KC) mice

av Leal, Ana S., Misek, Sean A., Lisabeth, Erika M., Neubig, Richard R., Liby, Karen T.
I publikationen Sci Rep (2019)

Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks

av Evelyn, Chris R., Lisabeth, Erika M., Wade, Susan M., Haak, Andrew J., Johnson, Craig N., Lawlor, Elizabeth R., Neubig, Richard R.
I publikationen Microarrays (Basel) (2016)

Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis

av Yu-Wai-Man, Cynthia, Spencer-Dene, Bradley, Lee, Richard M. H., Hutchings, Kim, Lisabeth, Erika M., Treisman, Richard, Bailly, Maryse, Larsen, Scott D., Neubig, Richard R., Khaw, Peng T.
I publikationen Sci Rep (2017)

Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds

av Lisabeth, Erika M., Kahl, Dylan, Gopallawa, Indiwari, Haynes, Sarah E., Misek, Sean A., Campbell, Phillip L., Dexheimer, Thomas S., Khanna, Dinesh, Fox, David A., Jin, Xiangshu, Martin, Brent R., Larsen, Scott D., Neubig, Richard R.
I publikationen ACS Pharmacol Transl Sci (2019)

Pharmacological inhibition of Myocardin-related transcription factor pathway blocks lung metastases of RhoC overexpressing melanoma

av Haak, Andrew J., Appleton, Kathryn M., Lisabeth, Erika M., Misek, Sean, Ji, Yajing, Wade, Susan M., Bell, Jessica L., Rockwell, Cheryl E., Airik, Merlin, Krook, Melanie A., Larsen, Scott D., Verhaegen, Monique, Lawlor, Elizabeth R., Neubig, Richard R.
I publikationen Mol Cancer Ther (2016)

Pharmacokinetic Optimization of CCG-203971: Novel Inhibitors of the Rho/MRTF/SRF Transcriptional Pathway as Potential Antifibrotic Therapeutics for Systemic Scleroderma

av Hutchings, Kim M., Lisabeth, Erika M., Rajeswaran, Walajapet, Wilson, Michael W., Sorenson, Roderick J., Campbell, Phillip L., Ruth, Jeffrey H., Amin, Asif, Tsou, Pei-Suen, Leipprandt, Jeffrey R., Olson, Samuel R., Wen, Bo, Zhao, Ting, Sun, Duxin, Khanna, Dinesh, Fox, David A., Neubig, Richard R., Larsen, Scott D.
I publikationen Bioorg Med Chem Lett (2017)